Wednesday, July 8, 2020

Skip to main page content

Search Page

Search Results

10 results
 
 
Bridging the gap between vaccination with Bacille Calmette-Guérin (BCG) and immunological tolerance: the cases of type 1 diabetes and multiple sclerosis.
Ristori G, Faustman D, Matarese G, Romano S, Salvetti M.Curr Opin Immunol. 2018 Dec;55:89-96. doi: 10.1016/j.coi.2018.09.016. Epub 2018 Nov 15.PMID: 30447407 Review.
At the end of past century, when the prevailing view was that treatment of autoimmunity required immune suppression, experimental evidence suggested an approach of immune-stimulation such as with the BCG vaccine in type 1 diabetes (T1D) and multiple sclerosis (MS). Transla …
 
 
Author response.
Ristori G, Romano S, Coarelli G, Buscarinu MC, Salvetti M.Neurology. 2014 Jul 22;83(4):381.PMID: 25184184 No abstract available.
 
 
Author response.
Ristori G, Romano S, Coarelli G, Buscarinu MC, Salvetti M.Neurology. 2014 Jul 15;83(3):293.PMID: 25157390 No abstract available.
 
 
Effects of Bacille Calmette-Guerin after the first demyelinating event in the CNS.
Ristori G, Romano S, Cannoni S, Visconti A, Tinelli E, Mendozzi L, Cecconi P, Lanzillo R, Quarantelli M, Buttinelli C, Gasperini C, Frontoni M, Coarelli G, Caputo D, Bresciamorra V, Vanacore N, Pozzilli C, Salvetti M.Neurology. 2014 Jan 7;82(1):41-8. doi: 10.1212/01.wnl.0000438216.93319.ab. Epub 2013 Dec 4.PMID: 24306002 Free PMC article. Clinical Trial.
OBJECTIVE: To evaluate Bacille Calmette-Guérin (BCG) effects after clinically isolated syndromes (CIS). METHODS: In a double-blind, placebo-controlled trial, participants were randomly assigned to receive BCG or placebo and monitored monthly with brain MRI (6 scans) …
 
 
Bacterial vaccines for the treatment of multiple sclerosis and other autoimmune disorders.
Rook GA, Ristori G, Salvetti M, Giovannoni G, Thompson EJ, Stanford JL.Immunol Today. 2000 Oct;21(10):503-8. doi: 10.1016/s0167-5699(00)01700-x.PMID: 11071529 Review. No abstract available.
 
 
Effects of Bacille Calmette-Guérin after the first demyelinating event in the CNS.
Sethi NK, Ristori G, Romano S, Coarelli G, Buscarinu MC, Salvetti M.Neurology. 2014 Jul 15;83(3):293. doi: 10.1212/01.wnl.0000452303.37990.ff.PMID: 25024446 No abstract available.
 
 
Use of Bacille Calmette-Guèrin (BCG) in multiple sclerosis.
Ristori G, Buzzi MG, Sabatini U, Giugni E, Bastianello S, Viselli F, Buttinelli C, Ruggieri S, Colonnese C, Pozzilli C, Salvetti M.Neurology. 1999 Oct 22;53(7):1588-9. doi: 10.1212/wnl.53.7.1588.PMID: 10534275 Clinical Trial.
We studied the effect of Bacille Calmette-Guerin (BCG) vaccine as an immunomodulator in MS. According to the guidelines for clinical trials in MS, a single crossover, MRI-monitored trial was performed in 14 patients with relapsing-remitting MS. ...Adjuvant therapy with …
 
 
The effect of Bacille Calmette-Guérin on the evolution of new enhancing lesions to hypointense T1 lesions in relapsing remitting MS.
Paolillo A, Buzzi MG, Giugni E, Sabatini U, Bastianello S, Pozzilli C, Salvetti M, Ristori G.J Neurol. 2003 Feb;250(2):247-8. doi: 10.1007/s00415-003-0967-6.PMID: 12622098 Clinical Trial. No abstract available.
 
 
Design of immunization programmes for developing countries.
Henderson DA, Labusquire R, Nicholson CC, Rey M, Ristori C, Dow PJ, Saroso JS, Millar JD.Paediatr Indones. 1972 Oct;12(10):409-26.PMID: 4679478
Selection of vaccines is treated in a separate appendix, but generally 3 groups are recognized: 1) recommended for general use: smallpox, diphtheria, tetanus, pertussis, BCG, typhoid and measles; 2) recommended for special cases: polio and yellow fever; 3) not recommended …
 

Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)